Cycling persister clones with elevated NR2F1-mediated cholesterol biosynthesis cause chemotherapy resistance
Hajime Sato, Taku Sato, Yohei Sasagawa…·Toshiaki Ohteki
The paper identifies cycling persisters (CPs) in cancer organoids and shows that elevated NR2F1-mediated cholesterol biosynthesis contributes to chemotherapy resistance.